Objective of the study

The main objectives of the study are

To present an overview of Beximco Pharmaceuticals Limited

To appraise the companys Dividend Policy
To analyze the relationship between dividend policy and market price of share.
To identify the problems
To suggest for reform
The objectives of this report is to make readers know about Beximco Pharmaceuticals
Limited and to provide information about its Dividend Policy

Scope and Methodology of the study

The report was mainly done by making some analytical approach. We have mainly used
derived/secondary data for the report. For this, we used the annual report, Dhaka Stock
Exchange website and companys website. For the accomplishment of our reports purpose, we
had chosen Beximco Pharmaceuticals Limited five year annual reports (FY 2010-2014). The
existing guiding principle, documents and other supporting papers important to this task were
also consulted and examined.

Origin of the report

Professor Dr. Tanbir Ahmed Chowdhury, Dean of Faculty of Business and Economics, East West
University as a course instructor of Corporate Finance (FIN 507) made us carry out the
accountability of preparing a report on An appraisal of the dividend policy by assigning it
during the mid part of this semester (Summer 2015) dated on 23/6/2015. We select Beximco
Pharmaceuticals Limited for the assignment. This report is required as a part of fulfilling the
objective of the course.

1|Pa ge

Limitation of the study

We try our best to make the report informative, error free and realistic. However, we could not
avoid some limitations, for which there might be some factual error in this report. Time
limitation is a major issue for the study work. Some limitations are as follows Time limitation is a major issue for the study work.
It may not be feasible to contact with investor to collect information or to have conversation
with them about dividend policy.
It will be harder to collect various data, books and journals related to the topic due to limited
accessibility of resources.
Many up-to-date data and documents may not be obtainable, which could have made the
study more informative. So a major constraint of the study will be the inadequate information.
Confidentiality of data was another barrier that was confronted during the conduct of the
study.
Our experience was very poor in comparison with the scope of study.

2|Pa ge

An overview of Beximco Pharmaceuticals Limited

Beximco Pharmaceuticals Limited (Beximco Pharma) is a leading manufacturer and exporter of
medicines in Bangladesh. Incorporated in the late 70s, Beximco Pharma has begin as a
distributor, importing products from global MNCs like Bayer, Germany, USA and selling them in
the local market, which were later manufactured and distributed under licensing arrangement.
Since then, the journey continued and today, Beximco Pharma is one of the largest exporters of
medicines in Bangladesh, winning National Export (Gold) Trophy, a record four times.
The company continues to adhere to the global standards and its manufacturing facilities have
been already certified by the regulatory authorities of Europe, Australia, Canada, Latin America
and South Africa. Over the last three decades Beximco Pharma has grown from strength to
strength but the simple principle on which it was founded remains the same Producing high
quality generics and making them affordable. Ensuring access to quality medicines is the
powerful aspiration that motivates more than 3,000 employees of the company and each of
them is guided by the same moral and social responsibilities the company values most.
Corporate Vision
We will be one of the most trusted, admired and successful pharmaceutical companies in the
region with a focus on strengthening research and development capabilities, creating
partnerships and building presence across the globe.
Corporate Mission
We are committed to enhancing human health and well-being by providing contemporary and
affordable medicines, manufactured in full compliance with global quality standards. We
continually strive to improve our core capabilities to address the unmet medical needs of the
patients and to deliver outstanding results for our shareholders.
Core Values
Beximco Pharmaceuticals Limited has the following cores values define who are they and what
guide them to take decisions and help realize their individual and corporate aspirations.

Commitment to quality

Customer satisfaction

People focus

Accountability

Corporate social responsibility

3|Pa ge

Achievements and Recognitions:

Year

Achievements and Recognitions

2014

First Bangladeshi company to receive GMP approval from Health Canada and
Taiwan Food and Drug Administration (TFDA)

2013

First Bangladeshi company to export ophthalmic products to Europe

2012

First Bangladeshi company to launch Salbutamol GFA inhaler (Azmasol) in

Singapore
Received GMP accreditation from AGES, Austria: only pharmaceutical company
to win National Export Trophy (Gold) for the fourth time

2011
2010

The only pharmaceutical company in Bangladesh to enter the US market

through acquisition of an Abbreviated New Drug Application (ANDA)

2009

Only Bangladeshi company to receive GMP approval from ANVISA, Brazil.

2008

First Bangladeshi Company to receive GMP accreditation from Therapeutic

Goods Administration (TGA), Australia and Gulf Central Committee for Drug
Registration, for GCC states.

2006

Launched CFC free HFA inhalers for the first time in Bangladesh.

Products Category
Allergic Disorders

Analgesics & Antipyretic

Analgesics & Antipyretic

Antiinfective

Cardiovascular

Central Nervous System

Cough & Cold

Endocrine & Diabetes

Eye Care

Gastrointestinal

Intravenous Fluids

Musculoskeletal

Oncology

Respiratory

Vitamins & Minerals Supplement

Skin Care & Other Products

4|Pa ge

5|Pa ge